Application of Sterylglucoside-Containing Particles for Drug Delivery

Author(s): Yoshie Maitani, Koji Nakamura, Kumi Kawano

Journal Name: Current Pharmaceutical Biotechnology

Volume 6 , Issue 1 , 2005

Become EABM
Become Reviewer
Call for Editor


Recent advances in biotechnology have promoted biomolecular targeting of drugs, peptides and genes in the treatment and management of major diseases and infections. Therapeutic development of drugs and delivery systems may have various objectives: Systemic drugs require optimal delivery and uptake at target sites; peptide drugs require alternative routes of administration, such as nasal or intestinal absorption; gene medicines need to be delivered efficiently, safely and selectively to diseased areas. The propensity of ligand-modified liposomes to carry drugs and genes to desirable sites has been extensively examined and current reports show considerable progress in this field. Sterylglucoside (SG) is a novel absorption-enhancer of peptide drugs across nasal and intestinal mucosae. Physico-chemical properties and biodistribution of liposomes incorporating SG were studied and compared against the profiles of aglycon and sitosterol derivatives of SG. It was shown that SG particles aided colon drug delivery and increased bioavailability of peptide drugs after nasal and intestinal administration. In addition, they were able to enhance anticancer effects in liver cancer chemotherapy. Biological fate and interaction of SG with hepatocytes support the novel proposition of liver-targeting SGliposomes.

Keywords: sterylglucoside, absorption enhancer, insulin, nasal absorption, nanoparticle, colon drug delivery, liver-targeting, anti-tumour drug

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [81 - 93]
Pages: 13
DOI: 10.2174/1389201053167194

Article Metrics

PDF: 20